Skip to the page

Data / Drug companies / Procter & Gamble Manufacturing GmbH

Procter & Gamble Manufacturing GmbH: 9 products in the FDA NDC directory, labeler code 64336

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Procter & Gamble Manufacturing GmbH (labeler code 64336) lists 9 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 9 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on February 27, 2026.

The request: Watch Procter & Gamble Manufacturing GmbH (FDA labeler code 64336): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
64336
Products in commercial distribution
9
Packages
16
Finished drugs by generic name
2
Prescription products
0
Over the counter products
9
Flagged as original packager
4 of 4 products that carry the flag
Started marketing in the last 12 months
4
Products with a marketing end date set
4
Earliest marketing start
April 27, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs9100%

Products by type

TypeProductsShare
Over the counter drugs9100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Spray888.9%
Ointment111.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

ClassProducts
Vasoconstrictor8

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Vicks SINEX SEVERE CONGESTION VapoCOOL ULTRA FINE MIST64336-005SprayOver the counter monograph drugsFebruary 27, 2026
Vicks Sinex SEVERE CONGESTION MOISTURIZING ULTRA FINE MIST64336-004SprayOver the counter monograph drugsFebruary 27, 2026
VICKS SINEX SEVERE CONGESTION ORIGINAL Ultra Fine Mist64336-003SprayOver the counter monograph drugsFebruary 27, 2026
Vicks Sinex SEVERE CONGESTION64336-002SprayOver the counter monograph drugsFebruary 27, 2026
Vicks VapoRub ADVANCED PLUS64336-001OintmentOver the counter monograph drugsJuly 6, 2023
Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST64336-173SprayOver the counter monograph drugsMay 1, 2020
Vicks Sinex Severe Original64336-170SprayOver the counter monograph drugsDecember 20, 2018
Vicks Sinex SEVERE MOISTURIZING ULTRA FINE MIST64336-015SprayOver the counter monograph drugsJuly 10, 2018
Vicks Sinex SEVERE ORIGINAL ULTRA FINE MIST64336-171SprayOver the counter monograph drugsApril 27, 2015

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.